Shilpa Gupta, Professor at Cleveland Clinic, shared on LinkedIn:
“International Bladder Cancer Group (IBCG) panel brought together patient advocates from around the world in collaboration with Bladder Cancer Advocacy, Network, World Bladder Cancer Patient Coalition reminding us why we do what we do and that the patient voice must remain at the center of everything we do in bladder cancer research and care.
Hearing directly from patients about their experiences, priorities, and what truly matters to them is essential as we work to advance research, design meaningful clinical trials, and improve outcomes.”
You might be interested in: Prognostic Value of Perioperative ctDNA Across Bladder Cancer Histologies
